SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-107223
Filing Date
2023-10-05
Accepted
2023-10-05 16:45:55
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2327633d1_s3.htm S-3 222415
2 EXHIBIT 23.2 tm2327633d1_ex23-2.htm EX-23.2 4213
3 EX-FILING FEES tm2327633d1_exfilingfees.htm EX-FILING FEES 41363
4 GRAPHIC tm2327633d1_s3img001.jpg GRAPHIC 7769
5 GRAPHIC tm2327633d1_img001.jpg GRAPHIC 14166
6 GRAPHIC tm2327633d1_img002.jpg GRAPHIC 2141
  Complete submission text file 0001104659-23-107223.txt   302761
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274880 | Film No.: 231311906
SIC: 2834 Pharmaceutical Preparations